Cell-permeable and plasma-stable peptidomimetic inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction

Journal of Medicinal Chemistry

Volumn 54, Issue 5, 2011, Pages 1333-1346

  Bach, Anders ^a   Eildal, Jonas N N ^a   Stuhr Hansen, Nicolai ^a   Deeskamp, Rasmus ^a   Gottschalk, Marie ^a   Pedersen, Søren W ^a   Kristensen, Anders S ^a   Strømgaard, Kristian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PEPTIDOMIMETIC AGENT; PEPTIDOMIMETIC INHIBITOR; POSTSYNAPTIC DENSITY PROTEIN 95; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL MEMBRANE PERMEABILITY; CELL STRAIN COS7; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; PEPTIDE SYNTHESIS; PLASMA; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL MEMBRANE PERMEABILITY; CERCOPITHECUS AETHIOPS; COS CELLS; DRUG STABILITY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MODELS, MOLECULAR; OLIGOPEPTIDES; PDZ DOMAINS; PEPTIDOMIMETICS; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79952271849     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1013924     Document Type: Article

References (53)

1. Arkin, M. R.; Wells, J. A. Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream Nat. Rev. Drug Discovery 2004, 3, 301-317 (Pubitemid 38499758)
2. Wells, J. A.; Mcclendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces Nature 2007, 450, 1001-1009 (Pubitemid 350273630)
3. Dev, K. K. Making protein interactions druggable: Targeting PDZ domains Nat. Rev. Drug Discovery 2004, 3, 1047-1056 (Pubitemid 39642367)
4. Gardoni, F.; Di Luca, M. New targets for pharmacological intervention in the glutamatergic synapse Eur. J. Pharmacol. 2006, 545, 2-10 (Pubitemid 44215874)
5. Wen, W.; Wang, W.; Zhang, M. Targeting PDZ domain proteins for treating NMDA receptor-mediated excitotoxicity Curr. Top. Med. Chem. 2006, 6, 711-721
6. Wang, N. X.; Lee, H. J.; Zheng, J. J. Therapeutic use of PDZ protein-protein interaction antagonism Drug News Perspect. 2008, 21, 137-141 (Pubitemid 351809136)
7. Blazer, L. L.; Neubig, R. R. Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: Current progress and future hurdles Neuropsychopharmacology 2009, 34, 126-141
8. + channels by interaction with a family of membrane-associated guanylate kinases Nature 1995, 378, 85-88
9. Kim, E.; Sheng, M. PDZ domain proteins of synapses Nat. Rev. Neurosci. 2004, 5, 771-781 (Pubitemid 39336214)
10. Elias, G. M.; Nicoll, R. A. Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins Trends Cell Biol. 2007, 17, 343-352 (Pubitemid 47102201)
11. Sheng, M.; Sala, C. PDZ domains and the organization of supramolecular complexes Annu. Rev. Neurosci. 2001, 24, 1-29 (Pubitemid 32695221)
12. Traynelis, S. F.; Wollmuth, L. P.; Mcbain, C. J.; Menniti, F. S.; Vance, K. M.; Ogden, K. K.; Hansen, K. B.; Yuan, H.; Myers, S. J.; Dingledine, R.; Sibley, D. Glutamate receptor ion channels: Structure, regulation, and function Pharmacol. Rev. 2010, 62, 405-496
13. Dawson, V. L.; Dawson, T. M.; London, E. D.; Bredt, D. S.; Snyder, S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6368-6371 (Pubitemid 21914947)
14. Sattler, R.; Xiong, Z.; Lu, W. Y.; Hafner, M.; Macdonald, J. F.; Tymianski, M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 Protein Sci. 1999, 284, 1845-1848
15. Garber, K. Stroke treatment-light at the end of the tunnel? Nat. Biotechnol. 2007, 25, 838-840
16. Ikonomidou, C.; Turski, L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002, 1, 383-386 (Pubitemid 37159164)
17. Christopherson, K. S.; Hillier, B. J.; Lim, W. A.; Bredt, D. S. PSD-95 assembles a ternary complex with the N -methyl- d -aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain J. Biol. Chem. 1999, 274, 27467-27473
18. Aarts, M.; Liu, Y.; Liu, L.; Besshoh, S.; Arundine, M.; Gurd, J. W.; Wang, Y. T.; Salter, M. W.; Tymianski, M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions Science 2002, 298, 846-850 (Pubitemid 35231541)
19. Soriano, F. X.; Martel, M. A.; Papadia, S.; Vaslin, A.; Baxter, P.; Rickman, C.; Forder, J.; Tymianski, M.; Duncan, R.; Aarts, M.; Clarke, P.; Wyllie, D. J.; Hardingham, G. E. Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand J. Neurosci. 2008, 28, 10696-10710
20. LeBlanc, B. W.; Iwata, M.; Mallon, A. P.; Rupasinghe, C. N.; Goebel, D. J.; Marshall, J.; Spaller, M. R.; Saab, C. Y. A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia Neuroscience 2010, 167, 490-500
21. Florio, S. K.; Loh, C.; Huang, S. M.; Iwamaye, A. E.; Kitto, K. F.; Fowler, K. W.; Treiberg, J. A.; Hayflick, J. S.; Walker, J. M.; Fairbanks, C. A.; Lai, Y. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents Br. J. Pharmacol. 2009, 158, 494-506
22. Tao, F.; Su, Q.; Johns, R. A. Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice Mol. Ther. 2008, 16, 1776-1782
23. Ittner, L. M.; Ke, Y. D.; Delerue, F.; Bi, M.; Gladbach, A.; Van Eersel, J.; Wolfing, H.; Chieng, B. C.; Christie, M. J.; Napier, I. A.; Eckert, A.; Staufenbiel, M.; Hardeman, E.; Götz, J. Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models Cell 2010, 142, 387-397
24. Lim, I. A.; Hall, D. D.; Hell, J. W. Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102 J. Biol. Chem. 2002, 277, 21697-21711 (Pubitemid 34952321)
25. Hung, A. Y.; Sheng, M. PDZ domains: Structural modules for protein complex assembly J. Biol. Chem. 2002, 277, 5699-5702 (Pubitemid 34968344)
26. Songyang, Z.; Fanning, A. S.; Fu, C.; Xu, J.; Marfatia, S. M.; Chishti, A. H.; Crompton, A.; Chan, A. C.; Anderson, J. M.; Cantley, L. C. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains Science 1997, 275, 73-77 (Pubitemid 27020310)
27. Stiffler, M. A.; Chen, J. R.; Grantcharova, V. P.; Lei, Y.; Fuchs, D.; Allen, J. E.; Zaslavskaia, L. A.; Macbeath, G. PDZ domain binding selectivity is optimized across the mouse proteome Science 2007, 317, 364-369
28. Bach, A.; Chi, C. N.; Olsen, T. B.; Pedersen, S. W.; Røder, M. U.; Pang, G. F.; Clausen, R. P.; Jemth, P.; Strømgaard, K. Modified peptides as potent inhibitors of the postsynaptic density-95/ N -methyl- d -aspartate receptor interaction J. Med. Chem. 2008, 51, 6450-6459
29. Bach, A.; Stuhr-Hansen, N.; Thorsen, T. S.; Bork, N.; Moreira, I. S.; Frydenvang, K.; Padrah, S.; Christensen, S. B.; Madsen, K. L.; Weinstein, H.; Gether, U.; Strømgaard, K. Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1 Org. Biomol. Chem. 2010, 8, 4281-4288
30. Hajduk, P. J.; Huth, J. R.; Fesik, S. W. Druggability indices for protein targets derived from NMR-based screening data J. Med. Chem. 2005, 48, 2518-2525 (Pubitemid 40516441)
31. Fry, D. C.; Vassilev, L. T. Targeting protein-protein interactions for cancer therapy J. Mol. Med. 2005, 83, 955-963 (Pubitemid 41745754)
32. Piserchio, A.; Salinas, G. D.; Li, T.; Marshall, J.; Spaller, M. R.; Mierke, D. F. Targeting specific PDZ domains of PSD-95; Structural basis for enhanced affinity and enzymatic stability of a cyclic peptide Chem. Biol. 2004, 11, 469-473 (Pubitemid 38503581)
33. Hammond, M. C.; Harris, B. Z.; Lim, W. A.; Bartlett, P. A. β Strand peptidomimetics as potent PDZ domain ligands Chem. Biol. 2006, 13, 1247-1251 (Pubitemid 44918388)
34. Udugamasooriya, D. G.; Sharma, S. C.; Spaller, M. R. A chemical library approach to organic-modified peptide ligands for PDZ domain proteins: A synthetic, thermodynamic and structural investigation ChemBioChem 2008, 9, 1587-1589
35. Bach, A.; Chi, C. N.; Pang, G. F.; Olsen, L.; Kristensen, A. S.; Jemth, P.; Strømgaard, K. Design and synthesis of highly potent and plasma-stable dimeric inhibitors of the PSD-95/NMDA receptor interaction Angew. Chem., Int. Ed. 2009, 48, 9685-9689
36. www.clinicaltrials.gov.
37. Doyle, D. A.; Lee, A.; Lewis, J.; Kim, E.; Sheng, M.; Mackinnon, R. Crystal structures of a complexed and peptide-free membrane protein-binding domain: Molecular basis of peptide recognition by PDZ Cell 1996, 85, 1067-1076 (Pubitemid 26231173)
38. Spatola, A. F. Peptide backbone modifications: Structure-activity analysis of peptides containing amide bond surrogates. In Chemistry and Biochemistry of Amino Acids, Peptides and Proteins; Weinstein, B., Ed.; Marcel Dekker: New York, 1983; Vol. 7, pp 267 - 357.
39. Mock, W. L.; Chen, J.-T.; Tsang, J. W. Hydrolysis of a thiopeptide by cadmium carboxypeptidase A Biochem. Biophys. Res. Commun. 1981, 102, 389-396
40. cat for peptide, but not ester, substrates J. Am. Chem. Soc. 1982, 104, 5221-5226
41. Bartlett, P. A.; Spear, K. L.; Jacobsen, N. E. A thioamide substrate of carboxypeptidase A Biochemistry 1982, 21, 1608-1611
42. Yao, S.; Zutshi, R.; Chmielewski, J. Endothiopeptide inhibitors of HIV-1 protease Bioorg. Med. Chem. Lett. 1998, 8, 699-704 (Pubitemid 28122378)
43. Maziak, L.; Lajoie, G.; Belleau, B. Productive conformation in the bound state and hydrolytic behavior of thiopeptide analogs of angiotensin-converting enzyme substrates J. Am. Chem. Soc. 1986, 108, 182-183 (Pubitemid 16171338)
44. La Cour, T. F. Stereochemistry of peptides containing a thioacyl group Int. J. Pept. Protein Res. 1987, 30, 564-571
45. Pogorelyi, V. K. Weak hydrogen bonds Russ. Chem. Rev. 1977, 46, 316-336
46. Pedersen, B. S.; Scheibye, S.; Nilsson, N. H.; Lawesson, S. O. Studies on organophosphorus compounds XX. Syntheses of thioketones Bull. Soc. Chim. Belg. 1978, 87, 223-228 (Pubitemid 8351308)
47. Jesberger, M.; Davis, T. P.; Barner, L. Applications of Lawesson's reagent in organic and organometallic syntheses Synthesis 2003, 1929-1958 (Pubitemid 37179946)
48. Bollhagen, R.; Schmiedberger, M.; Kleomenis, B.; Grell, E. A new reagent for the cleavage of fully protected peptides synthesised on 2-chlorotrityl chloride resin J. Chem. Soc. Chem. Commun. 1994, 29, 2559-2560
49. Gottschalk, M.; Bach, A.; Hansen, J. L.; Krogsgaard-Larsen, P.; Kristensen, A. S.; Strømgaard, K. Detecting protein-protein interactions in living cells: Development of a bioluminescence resonance energy transfer assay to evaluate the PSD-95/NMDA receptor interaction Neurochem. Res. 2009, 34, 1729-1737
50. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13003-13008
51. Trehin, R.; Merkle, H. P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery Eur. J. Pharm. Biopharm. 2004, 58, 209-223 (Pubitemid 39037230)
52. Delano, W. L. The pymol molecular graphics system on world wide web; http://www.Pymol.Org.
53. Nikolovska-Coleska, Z.; Wang, R.; Fang, X.; Pan, H.; Tomita, Y.; Li, P.; Roller, P. P.; Krajewski, K.; Saito, N. G.; Stuckey, J. A.; Wang, S. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization Anal. Biochem. 2004, 332, 261-273 (Pubitemid 39485734)